FAST NEWS: Simcere Pharma New Co-CEO Sends Investors Scurrying
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced late Wednesday that executive director Tang Renhong has been appointed as Co-CEO and will assist Chairman and CEO Ren Jinsheng in leading…
Recent Articles
RELATED ARTICLES
-
NEWS WRAP: DouYu names new CEO, declares massive dividend to entice investors
DOYU.US - Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
- Innogen Pharma jostles for a slice of the weight-loss market
